Anti-inflammatory activity of baicalein in LPS-stimulated RAW264.7 macrophages via estrogen receptor and NF-κB-dependent pathways

Inflammation

Volumn 36, Issue 6, 2013, Pages 1584-1591

  Fan, Guan Wei ^a   Zhang, Yuan ^a   Jiang, Xiaorui ^a   Zhu, Yan ^a   Wang, Bingyao ^a   Su, Lina ^a   Cao, Wenjie ^a   Zhang, Han ^a   Gao, Xiumei ^a  

^a TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

baicalein; estrogen like activity; inflammation; NF kB; phytoestrogen; RAW264.7 cells

Indexed keywords

BAICALEIN; CYCLOOXYGENASE 2; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL STRAIN; CELL STRAIN RAW264.7; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; MACROPHAGE ACTIVATION; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; CYCLOOXYGENASE 2; DINOPROSTONE; FLAVANONES; HELA CELLS; HUMANS; I-KAPPA B PROTEINS; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MACROPHAGES; MEDICINE, CHINESE TRADITIONAL; MICE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHORYLATION; RECEPTORS, ESTROGEN; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84888205018     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-013-9703-2     Document Type: Article

References (29)

1. Lagari, V.S., and S. Levis. 2010. Phytoestrogens and bone health. Current Opinion in Endocrinology, Diabetes, and Obesity 17: 546-553.
2. Fan, G.W., X.M. Gao, H. Wang, Y. Zhu, J. Zhang, L.M. Hu, Y.F. Su, L.Y. Kang, and B.L. Zhang. 2009. The anti-inflammatory activities of Tanshinone IIA, an active component of TCM, are mediated by estrogen receptor activation and inhibition of iNOS. The Journal of Steroid Biochemistry and Molecular Biology 113: 275-280.
3. Xin, D., H. Wang, J. Yang, Y.F. Su, G.W. Fan, Y.F. Wang, Y. Zhu, and X.M. Gao. 2010. Phytoestrogens from Psoralea corylifolia reveal estrogen receptor-subtype selectivity. Phytomedicine 17: 126-131.
4. Rossol, M., H. Heine, U. Meusch, D. Quandt, C. Klein, M.J. Sweet, and S. Hauschildt. 2011. LPS-induced cytokine production in human monocytes and macrophages. Critical Reviews in Immunology 31: 379-446.
5. Heine, H., E.T. Rietschel, and A.J. Ulmer. 2001. The biology of endotoxin. Molecular Biotechnology 19: 279-296.
6. Bhatia, M., and S. Moochhala. 2004. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. The Journal of Pathology 202: 145-156.
7. Watanabe, K., K. Jinnouchi, A. Hess, O. Michel, and T. Yagi. 2001. Detection of apoptotic change in the lipopolysaccharide (LPS)-treated cochlea of guinea pigs. Hearing Research 158: 116-122.
8. DiDonato, J.A., F. Mercurio, and M. Karin. 2012. NF-kappaB and the link between inflammation and cancer. Immunological Reviews 246: 379-400.
9. Christman, J.W., L.H. Lancaster, and T.S. Blackwell. 1998. Nuclear factor kappa B: a pivotal role in the systemic inflammatory response syndrome and new target for therapy. Intensive Care Medicine 24: 1131-1138.
10. Ghosh, S., and M.S. Hayden. 2008. New regulators of NF-kappaB in inflammation. Nature Reviews Immunology 8: 837-848.
11. Edwards, M.R., N.W. Bartlett, D. Clarke, M. Birrell, M. Belvisi, and S.L. Johnston. 2009. Targeting the NF-kappaB pathway in asthma and chronic obstructive pulmonary disease. Pharmacology and Therapeutics 121: 1-13.
12. Wong, E.T., and V. Tergaonkar. 2009. Roles of NF-kappaB in health and disease: mechanisms and therapeutic potential. Clinical Science (London, England) 116: 451-465.
13. Lin, C.C., and D.E. Shieh. 1996. The anti-inflammatory activity of Scutellaria rivularis extracts and its active components, baicalin, baicalein and wogonin. The American Journal of Chinese Medicine 24: 31-36.
14. Wakabayashi, I. 1999. Inhibitory effects of baicalein and wogonin on lipopolysaccharide-induced nitric oxide production in macrophages. Pharmacology and Toxicology 84: 288-291.
15. Cheng, P.Y., Y.M. Lee, Y.S. Wu, T.W. Chang, J.S. Jin, and M.H. Yen. 2007. Protective effect of baicalein against endotoxic shock in rats in vivo and in vitro. Biochemical Pharmacology 73: 793-804.
16. Woo, K.J., J.H. Lim, S.I. Suh, Y.K. Kwon, S.W. Shin, S.C. Kim, Y.H. Choi, J.W. Park, and T.K. Kwon. 2006. Differential inhibitory effects of baicalein and baicalin on LPS-induced cyclooxygenase-2 expression through inhibition of C/EBPbeta DNA-binding activity. Immunobiology 211: 359-368.
17. Singh, A.K., R. Singh, F. Naz, S.S. Chauhan, A. Dinda, A.A. Shukla, K. Gill, V. Kapoor, and S. Dey. 2012. Structure based design and synthesis of peptide inhibitor of human LOX-12: in vitro and in vivo analysis of a novel therapeutic agent for breast cancer. PloS One 7: e32521.
18. Chakrabarti, S., O. Lekontseva, and S.T. Davidge. 2008. Estrogen is a modulator of vascular inflammation. IUBMB Life 60: 376-382.
19. Ji, G., Y. Zhang, Q. Yang, S. Cheng, J. Hao, X. Zhao, and Z. Jiang. 2012. Genistein suppresses LPS-induced inflammatory response through inhibiting NF-kappaB following AMP kinase activation in RAW 264.7 macrophages. PloS One 7: e53101.
20. Hao, J., F.-D. Shi, M. Abdelwahab, S.X. Shi, A. Simard, P. Whiteaker, R. Lukas, and Q. Zhou. 2013. Nicotinic receptor beta2 determines NK cell-dependent metastasis in a murine model of metastatic lung cancer. PloS One 8: e57495-e57495.
21. Shao, Z.H., T.L. Vanden Hoek, Y. Qin, L.B. Becker, P.T. Schumacker, C.Q. Li, L. Dey, E. Barth, H. Halpern, G.M. Rosen, and C.S. Yuan. 2002. Baicalein attenuates oxidant stress in cardiomyocytes. American Journal of Physiology - Heart and Circulatory Physiology 282: H999-H1006.
22. Hsieh, C.J., K. Hall, T. Ha, C. Li, G. Krishnaswamy, and D.S. Chi. 2007. Baicalein inhibits IL-1beta- and TNF-alpha-induced inflammatory cytokine production from human mast cells via regulation of the NF-kappaB pathway. Clinical and Molecular Allergy: CMA 5: 5.
23. Yang, L.P., H.L. Sun, L.M. Wu, X.J. Guo, H.L. Dou, M.O. Tso, L. Zhao, and S.M. Li. 2009. Baicalein reduces inflammatory process in a rodent model of diabetic retinopathy. Investigative Ophthalmology and Visual Science 50: 2319-2327.
24. Pettersson, K., and J.A. Gustafsson. 2001. Role of estrogen receptor beta in estrogen action. Annual Review of Physiology 63: 165-192.
25. Jobin, C., C.A. Bradham, M.P. Russo, B. Juma, A.S. Narula, D.A. Brenner, and R.B. Sartor. 1999. Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. The Journal of Immunology 163: 3474-3483.
26. Chi, D.S., T.C. Lin, K. Hall, T. Ha, C. Li, Z.D. Wu, T. Soike, and G. Krishnaswamy. 2012. Enhanced effects of cigarette smoke extract on inflammatory cytokine expression in IL-1beta-activated human mast cells were inhibited by baicalein via regulation of the NF-kappaB pathway. Clinical and Molecular Allergy: CMA 10: 3.
27. Bremner, P., and M. Heinrich. 2002. Natural products as targeted modulators of the nuclear factor-kappaB pathway. The Journal of Pharmacy and Pharmacology 54: 453-472.
28. Kasinski, A.L., Y. Du, S.L. Thomas, J. Zhao, S.Y. Sun, F.R. Khuri, C.Y. Wang, M. Shoji, A. Sun, J.P. Snyder, D. Liotta, and H. Fu. 2008. Inhibition of IkappaB kinase-nuclear factor-kappaB signaling pathway by 3,5-bis(2- flurobenzylidene)piperidin-4-one (EF24), a novel monoketone analog of curcumin. Molecular Pharmacology 74: 654-661.
29. Kim, B.H., E. Roh, H.Y. Lee, I.J. Lee, B. Ahn, S.H. Jung, H. Lee, S.B. Han, and Y. Kim. 2008. Benzoxathiole derivative blocks lipopolysaccharide- induced nuclear factor-kappaB activation and nuclear factor-kappaB-regulated gene transcription through inactivating inhibitory kappaB kinase beta. Molecular Pharmacology 73: 1309-1318.